维普期刊资源整合服务平台（V6.5）

129篇 您的检索式：作者名="Seror"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Tolerance and efficacy ofrituximab and changes in serum B cell biomarkers in patientswith systemic complications of primary Sjagren's syndrome 显示文摘	Seror R Sordet C Guillevin L	2007	Ann Rheum Dis2007，66，3：	1
2	EULAR Sjogren's syn- drome disease activity index: development of a consensus sys- temic disease activity index for primary Sjogren's syndrome显示文摘	Seror R Ravaud P Bowman SJ	2010	Ann Rheum Dis2010，69，：	1
3	Ablative therapies:advantages and disadvantages of radiofrequency,cryotherapy,microwave and electroporation methods,or how to choose the right method for an individual patient?显示文摘	O Seror	2015	Dlagnostic and Interventional Imaging2015，96，：	1
4	Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients 显示文摘	N'Kontchou G Seror O Bourcier V	2005	Eur J Gastroenterol Hepatol2005，17，2：	1
5	Idiopathic lumbosacral plexopathy显示文摘	Seror P Maisonobe T Viala K	2005	Presse Med2005，34，12：	1
6	Outcome measures for primary Sjogren's syndrome显示文摘	Seror R Bootsma H Bowman SJ	2012	J Autoimmun2012，39，12：	1
7	The Five- Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort 显示文摘	Guillevin L Pagnoux C Seror R	2011	Medicine ( Baltimore)2011，90，：	1
8	Efficacy and safety of belimumab in primary Sj6gren's syndrome: results of the BELISS open-label phase II study显示文摘	Mariette X Seror R Quartuccio L	2015	Ann Rheum Dis2015，74，3：	1
9	Water - soluble contrast ma- terial has no therapeutic effect on postoperative small bowel ob- struction :results of a prospective, randomized clinical trial 显示文摘	Feigin E Seror I) Szold A	1996	Am J Surg1996，171，2：	1
10	Transcription in theprpC-yloQ region in Bacillus subtilis 显示文摘	Iwanicki A Hinc K Seror S	2005	Arch Microbiol2005，183，：	1
11	Platelet alloimmunization after multiple transfusions:a prospective study of 50 patients显示文摘	Codeau B Fremont P Seror T	1992	Br J Haematol1992，81，3：	1
12	Sensibillite in vitro aux antibiotiques des mycoplasmes genitaux isoles a Toulouse显示文摘	Bauriaud R Seror C Lareng MB	1992	Path Biol1992，40，5：	1
13	Characteristics, prognosis,and outcomes of cutaneous ischemia and gangrene in systemic ne-crotizing vasculitides: A retrospective multicenter study 显示文摘	Lega JC Seror R Fassier T	2014	Se-min Arthritis Rheu2014，4，3：	1
14	Ophthalmologicmanifestations of systemic necrotizing vasculitides at diagnosis :a retrospective study of 1286 patients and review of the literature显示文摘	Rothschild PR Pagnoux C Seror R	2013	Semin Arthritis Rheum2013，42，5：	1
15	The Five-Factor Score revisited, assessment of prognoses of systemic necrotizing vas- culitides based on the french vasculitis study group (FVSG) cohort显示文摘	Guillevin L Pagnoux C Seror R	2011	Medicine (Baltimore)2011，90，1：	1
16	Clinical features and outcomes in 348 patients with polyarteritis nodosa显示文摘	Pagnoux C Seror R Henegar C		0，，：	1
17	Scleroderma renal crisis:a retrospective multicentre study on 91patients and427controls显示文摘	Guillevin L BéreznéA Seror R	2012	Rheumatology(Oxford)2012，51，3：	1
18	Outcome measures for pri- mary Sjtigren' s syndrome : A comprehensive review 显示文摘	Seror R Theander E Bootsma H	2014	J Autoim- mun2014，，51：	1
19	EULAR Sjogren's syndrome disease activity index:development of a consensus systemic dis- ease activity index for primary Sjogren's syndrome显示文摘	Seror R Ravaud P Bowman SJ	2010	ANN Rheum Dis2010，69，6：	1
20	EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome 显示文摘	Seror R Ravaud P Bowman S] ~t al	2010	Ann Rheum Dis2010，69，6：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示